BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,854 Cr | ₹-2,333 Cr | ₹13,049 Cr | ₹242 Cr | ₹2,564 Cr |
What is the latest Cash Flow from Financing Activities ratio of BIOCON ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1,854 Cr |
| Mar2024 | ₹-2,333 Cr |
| Mar2023 | ₹13,049 Cr |
| Mar2022 | ₹242 Cr |
| Mar2021 | ₹2,564 Cr |
How is Cash Flow from Financing Activities of BIOCON Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,854 Cr | Negative | |
| Mar2024 | ₹-2,333 Cr | Negative | |
| Mar2023 | ₹13,049 Cr | 5,289.80 | |
| Mar2022 | ₹242 Cr | -90.56 | |
| Mar2021 | ₹2,564 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹60,945.8 Cr | 1.1% | -2.7% | -2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 1.1% |
-2.7% |
-2.6% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses